OTC Markets OTCPK - Delayed Quote USD
LianBio (LIANY)
0.2000
+0.0165
+(8.99%)
At close: May 9 at 2:51:56 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
Operating Expense
106,559
125,353
195,570
134,869
Operating Income
-106,559
-125,353
-195,570
-134,869
Net Non Operating Interest Income Expense
9,950
4,321
243
-4,854
Other Income Expense
9,502
10,409
-455
123
Pretax Income
-87,107
-110,623
-195,782
-139,600
Tax Provision
874
-333
518
4
Net Income Common Stockholders
-87,981
-110,290
-196,300
-139,604
Diluted NI Available to Com Stockholders
-87,981
-110,290
-196,300
-139,604
Basic EPS
-0.82
-1.02
-5.71
-1.33
Diluted EPS
-0.82
-1.02
-5.71
-1.33
Basic Average Shares
107,405.9100
107,923.2960
34,394.6220
105,257.0140
Diluted Average Shares
107,405.9100
107,923.2960
34,394.6220
105,257.0140
Total Operating Income as Reported
-106,559
-125,353
-195,570
-134,869
Total Expenses
106,559
125,353
195,570
134,869
Net Income from Continuing & Discontinued Operation
-87,981
-110,290
-196,300
-139,604
Normalized Income
-87,981
-110,290
-196,300
-139,604
Net Interest Income
9,950
4,321
243
-4,854
EBIT
-106,559
-125,353
-195,570
-134,869
EBITDA
-105,259
-124,347
-195,045
-134,793
Reconciled Depreciation
1,300
1,006
525
76
Net Income from Continuing Operation Net Minority Interest
-87,981
-110,290
-196,300
-139,604
Normalized EBITDA
-105,259
-124,347
-195,045
-134,793
Tax Rate for Calcs
0.0002
0
0.0003
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2020 - 11/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade